Barry Kapik

2.0k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Barry Kapik is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pharmacology. According to data from OpenAlex, Barry Kapik has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Ophthalmology, 10 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Pharmacology. Recurrent topics in Barry Kapik's work include Retinal Diseases and Treatments (21 papers), Retinal and Optic Conditions (11 papers) and Glaucoma and retinal disorders (11 papers). Barry Kapik is often cited by papers focused on Retinal Diseases and Treatments (21 papers), Retinal and Optic Conditions (11 papers) and Glaucoma and retinal disorders (11 papers). Barry Kapik collaborates with scholars based in United States, United Kingdom and France. Barry Kapik's co-authors include Frances Kane, Peter A. Campochiaro, Thomas A. Ciulla, Amod Gupta, David S. Boyer, Andrew Pearson, David M. Brown, Clare Bailey, Frank G. Holz and Ken Green and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and The Journal of Pediatrics.

In The Last Decade

Barry Kapik

31 papers receiving 1.4k citations

Hit Papers

Sustained Delivery Fluocinolone Acetonide Vitreous Insert... 2012 2026 2016 2021 2012 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
    2012 376 citations Peter A. Campochiaro, David M. Brown et al. Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Kapik United States 17 1.2k 808 187 161 97 32 1.5k
Ümit Ubeyt İnan Türkiye 18 652 0.5× 357 0.4× 92 0.5× 113 0.7× 33 0.3× 63 833
Marilita M Moschos Greece 16 571 0.5× 285 0.4× 147 0.8× 88 0.5× 26 0.3× 52 832
Osman Çekıç Türkiye 25 1.4k 1.1× 936 1.2× 230 1.2× 154 1.0× 19 0.2× 100 1.8k
Gunnar Høvding Norway 19 562 0.5× 427 0.5× 140 0.7× 353 2.2× 20 0.2× 68 1.2k
Salvador García Delpech Spain 14 514 0.4× 322 0.4× 88 0.5× 111 0.7× 30 0.3× 71 753
Jayter Silva Paula Brazil 19 717 0.6× 497 0.6× 117 0.6× 368 2.3× 15 0.2× 95 1.2k
Paul Karpecki United States 23 1.2k 1.0× 868 1.1× 80 0.4× 2.4k 15.1× 43 0.4× 68 2.9k
Hugo Y. Hsu United States 16 508 0.4× 256 0.3× 45 0.2× 219 1.4× 33 0.3× 36 714
Suqin Guo United States 15 301 0.3× 262 0.3× 98 0.5× 73 0.5× 29 0.3× 44 773
Vicki Evans Australia 11 789 0.7× 608 0.8× 63 0.3× 1.4k 8.4× 12 0.1× 24 1.6k

Countries citing papers authored by Barry Kapik

Since Specialization
Citations

This map shows the geographic impact of Barry Kapik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Kapik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Kapik more than expected).

Fields of papers citing papers by Barry Kapik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Kapik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Kapik. The network helps show where Barry Kapik may publish in the future.

Co-authorship network of co-authors of Barry Kapik

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Kapik. A scholar is included among the top collaborators of Barry Kapik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Kapik. Barry Kapik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barakat, Mark, David M. Brown, Rahul N. Khurana, et al.. (2024). Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial. SHILAP Revista de lepidopterología. 5(1). 100586–100586. 4 indexed citations
2.
Nittala, Muneeswar Gupta, Ahmed Roshdy Alagorie, Zhihong Hu, et al.. (2023). OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema. Canadian Journal of Ophthalmology. 59(2). 109–118. 3 indexed citations
3.
Ciulla, Thomas A., Barry Kapik, Allen Hu, et al.. (2022). Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion. Ophthalmology Retina. 6(12). 1206–1220. 7 indexed citations
4.
Shah, Milan, et al.. (2021). Post hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious Uveitis. Investigative Ophthalmology & Visual Science. 62(8). 1192–1192. 1 indexed citations
5.
Sharma, Sumit, et al.. (2021). Safety of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders. Investigative Ophthalmology & Visual Science. 62(8). 1209–1209. 3 indexed citations
6.
Khurana, Rahul N., Pauline T. Merrill, Steven Yeh, et al.. (2021). Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA). British Journal of Ophthalmology. 106(8). bjophthalmol–2020. 34 indexed citations
7.
Ciulla, Thomas A., Barry Kapik, Mark Barakat, et al.. (2021). Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema. American Journal of Ophthalmology. 237. 310–324. 10 indexed citations
8.
Barakat, Mark, et al.. (2020). Post hoc Analysis of Clinical Suprachoroidal Injection Experience across Indications. Investigative Ophthalmology & Visual Science. 61(7). 4954–4954. 3 indexed citations
9.
Ciulla, Thomas A., Barry Kapik, Dilraj S. Grewal, & Michael S. Ip. (2020). Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema. Ophthalmology Retina. 5(7). 633–647. 25 indexed citations
10.
11.
Kaufman, David, et al.. (2014). Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety. Early Human Development. 90. S87–S90. 12 indexed citations
12.
Campochiaro, Peter A., David M. Brown, Andrew Pearson, et al.. (2012). Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema. Ophthalmology. 119(10). 2125–2132. 376 indexed citations breakdown →
13.
Campochiaro, Peter A., David M. Brown, Andrew Pearson, et al.. (2011). Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema. Ophthalmology. 118(4). 626–635.e2. 288 indexed citations
14.
Campochiaro, Peter A., Gulnar Hafiz, Syed Mahmood Shah, et al.. (2010). Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal Insert. Ophthalmology. 117(7). 1393–1399.e3. 117 indexed citations
15.
Burchfield, David J., Barry T. Bloom, Mark J. Polak, et al.. (2007). Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants. The Journal of Pediatrics. 151(3). 260–265.e1. 114 indexed citations
16.
McCarey, Bernard E., Barry Kapik, & Frances Kane. (2004). Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%. Ophthalmology. 111(8). 1480–1488. 18 indexed citations
17.
Greiner, Jack V., Thomas K. Mundorf, Harvey Dubiner, et al.. (2003). Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. American Journal of Ophthalmology. 136(6). 1097–1105. 26 indexed citations
18.
Abelson, Mark B., et al.. (2002). Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Advances in Therapy. 19(4). 161–169. 9 indexed citations
19.
20.
Brunden, Marshall N., Gary E. Zurenko, & Barry Kapik. (1992). Modification of the error-rate bounded classification scheme for use with two MIC break points. Diagnostic Microbiology and Infectious Disease. 15(2). 135–140. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ümit Ubeyt İnan Breakdown of academic impact, for papers by Marilita M Moschos Breakdown of academic impact, for papers by Osman Çekıç Breakdown of academic impact, for papers by Gunnar Høvding Breakdown of academic impact, for papers by Salvador García Delpech Breakdown of academic impact, for papers by Jayter Silva Paula Breakdown of academic impact, for papers by Paul Karpecki Breakdown of academic impact, for papers by Hugo Y. Hsu Breakdown of academic impact, for papers by Suqin Guo Breakdown of academic impact, for papers by Vicki Evans
Rankless by CCL
2026